83 related articles for article (PubMed ID: 1852327)
1. Adjuvant therapy of colon cancer: what should we be doing.
Harvey VJ
N Z Med J; 1991 Jul; 104(915):280-1. PubMed ID: 1852327
[No Abstract] [Full Text] [Related]
2. Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.
Skillings JR; Levine M; Rayner HL; Eisenhauer E; Erlichman C; Germond C; Kerr I; Lofters W; Maroun J; Yoshida S
CMAJ; 1991 Feb; 144(3):297-301. PubMed ID: 1989708
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for stage II colon cancer: the time has come.
Mamounas EP
Eur J Surg Oncol; 2000 Dec; 26(8):725-9. PubMed ID: 11087634
[No Abstract] [Full Text] [Related]
4. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04].
Schumacher K
Strahlenther Onkol; 2000 May; 176(5):239-40. PubMed ID: 10847122
[No Abstract] [Full Text] [Related]
6. Levamisole as an adjuvant in cancer treatment.
Janssen PA
J Clin Pharmacol; 1991 May; 31(5):396-400. PubMed ID: 2050823
[No Abstract] [Full Text] [Related]
7. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
[TBL] [Abstract][Full Text] [Related]
8. Levamisole in the adjuvant treatment of colon cancer.
Mutch RS; Hutson PR
Clin Pharm; 1991 Feb; 10(2):95-109. PubMed ID: 2009737
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy in early breast cancer.
Chittoor SR; Swain SM
Am Fam Physician; 1991 Aug; 44(2):453-62. PubMed ID: 1858602
[TBL] [Abstract][Full Text] [Related]
10. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
11. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for colon and rectal cancer.
Ratkin GA
Am Fam Physician; 1997 May; 55(7):2487-92, 2495-6. PubMed ID: 9166147
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant systemic chemo- or immunotherapy of colon cancer].
Schlag PM
Chirurg; 1994 Jun; 65(6):503-8. PubMed ID: 8088205
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy of colorectal cancer.
Kemeny N; Saltz L; Cohen A
Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
[TBL] [Abstract][Full Text] [Related]
15. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant therapy for colon cancer].
Moiseenko VM; Orlova RV
Vopr Onkol; 1998; 44(6):741-5. PubMed ID: 10087982
[No Abstract] [Full Text] [Related]
17. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Glimelius B; Dahl O; Cedermark B; Jakobsen A; Bentzen SM; Starkhammar H; Grönberg H; Hultborn R; Albertsson M; Påhlman L; Tveit KM;
Acta Oncol; 2005; 44(8):904-12. PubMed ID: 16332600
[TBL] [Abstract][Full Text] [Related]
18. Trustworthy alteration and improvement in adjuvant treatment of colon cancer.
Harlak A; Soran A
Med Sci Monit; 2006 Mar; 12(3):RA46-52. PubMed ID: 16501433
[TBL] [Abstract][Full Text] [Related]
19. Levamisole as a therapeutic agent for colorectal carcinoma.
Grem JL
Cancer Cells; 1990 May; 2(5):131-7. PubMed ID: 2201339
[TBL] [Abstract][Full Text] [Related]
20. [Severe myalgias: an unusual undesirable effect of levamisole combined with 5-fluorouracil].
Buecher B; Blanc JF; Magnien F; Bechade D; Lapprand M; Oddes B
Gastroenterol Clin Biol; 1996; 20(4):407-8. PubMed ID: 8758514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
